CONTRAST DIAGNOSTICS GAMMA LTD
Company number 13910111 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
CONTRAST DIAGNOSTICS GAMMA LTD - Analysis Report
Company Number: 13910111
Analysis Date: 2025-07-20 17:07 UTC
Risk Rating: HIGH
The company shows minimal financial activity and extremely limited assets, with consistent figures of only £1,000 in debtors, shareholders’ funds, and net assets over multiple years. The accounts indicate the company was dormant throughout the reported periods, which raises significant concerns about operational viability and financial substance.Key Concerns:
- Dormant Status: The company’s accounts explicitly state it has been dormant, implying no trading activity or revenue generation, which questions its capacity to meet obligations or generate cash flow.
- Minimal Financial Footprint: Total assets less current liabilities and shareholders’ funds remain constant at £1,000 over four years, suggesting no growth or operational development.
- Lack of Audit and Limited Reporting: The company has taken advantage of audit exemptions and small company reporting provisions, limiting transparency and potentially masking financial or operational risks.
- Positive Indicators:
- Compliance with Filing Deadlines: The company is up to date with its accounts and confirmation statement filings, showing no overdue submissions or regulatory breaches.
- Single Director with Full Control: Mr. Andrew John Unwin is the sole director and 100% owner, which simplifies governance and decision-making processes.
- Active Status: The company remains active and not in liquidation or administration, indicating no immediate formal insolvency proceedings.
- Due Diligence Notes:
- Verify the nature and timeline of the company’s intended business activities and whether it plans to commence trading, as current dormancy limits assessment of operational risks.
- Review any off-balance sheet commitments or contingent liabilities not disclosed in the accounts.
- Assess the director’s plans and financial backing to support future operations, including capital injections or funding arrangements.
- Investigate whether the company holds any intellectual property, licenses, or agreements that might add intangible value not reflected in the minimal balance sheet.
- Confirm the accuracy of the debtor and asset figures and whether these represent any meaningful receivables or cash equivalents.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.